Immuno-Oncology: From Science Fiction to the Mainstream
In just a couple of decades, immuno-oncology has taken center stage in the biotechnology industry.…
26/05/2021 - 7 minutes
Cancer
ADVERTISEMENT
Do you want to remove this advert? Become a member!
ADC Approval Buoys Spirits in Cancer Treatment Space
The FDA recently approved an antibody-drug conjugate drug from ADC Therapeutics as a treatment for…
11/05/2021 - 7 minutes
BMS’s Cancer Trial Showcases Potential for Checkpoint Inhibitors
Bristol Myers Squibb’s recent phase III success provided the first late-stage confirmation for a novel…
29/04/2021 - 5 minutes
Pandemic Boosts Diagnostics Field with High Revenues and Acquisitions
The US medtech firm Hologic has bought the Finnish-French biotech Mobidiag for around €668M in…
20/04/2021 - 5 minutes
Achilles Therapeutics’ IPO Caps Investment Wave for Neoantigens
The close of the UK firm Achilles Therapeutics’ €146.9M ($175.5M) initial public offering last month…
15/04/2021 - 5 minutes
Eight Diseases CRISPR Technology Could Cure
CRISPR technology offers the promise to cure any human genetic disease with gene editing; which…
13/04/2021 - 9 minutes
Artios-Novartis Pact Pushes Limits of DNA Repair in Cancer
A €1.1B deal struck this week between Novartis and the UK-based company Artios Pharma forges…
08/04/2021 - 5 minutes
Base Editing: The Next Frontier in Genome Editing Technology
Jonathan Frampton, Corporate Development Partner at Horizon Discovery, a Perkin Elmer company, shares his insights…
05/04/2021 - 4 minutes
Lava Therapeutics’ IPO Shakes Cancer Niche of Gamma Delta T Cells
The Dutch biotech startup Lava Therapeutics launched onto the Nasdaq stock market last week with…
31/03/2021 - 5 minutes
Developing a Vaccine that Protects Against Covid-19 Variants
Despite the promise of several approved Covid-19 vaccines and the widespread rollout of vaccination programs…
15/03/2021 - 8 minutes
Advice for my Younger Self: How to Be a VC in Life Sciences
Antoine Papiernik, Chairman and Managing Partner at Sofinnova Partners, looks back at where he was…
08/03/2021 - 5 minutes
The Promises of CRISPR Genome Editing in Biomedicine
Tony Ho, Head of Research and Development at CRISPR Therapeutics, offers his insights into the…
03/03/2021 - 5 minutes
